GB Patent

GB9003939D0 — Sulphatase inhibitors

Assigned to Imperial College of London · Expires 1990-04-18 · 36y expired

What this patent protects

Novel steroid 3-thiophosphonates are disclosed which are useful as steroid sulphatase inhibitors.

USPTO Abstract

Novel steroid 3-thiophosphonates are disclosed which are useful as steroid sulphatase inhibitors.

Drugs covered by this patent

Abilify (aripiprazole) · Generic (originally Otsuka/BMS)

Patent Metadata

Patent number: GB9003939D0
Jurisdiction: GB
Classification: —
Expires: 1990-04-18
Drug substance claim: No
Drug product claim: No
Assignee: Imperial College of London
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.